Thu, Sep 18, 2014, 7:37 AM EDT - U.S. Markets open in 1 hr 53 mins


% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • lilgodfther lilgodfther Jul 2, 2013 9:58 AM Flag

    Seking Alpha E-Mail, Price Target $22.00

    9:50 AM "We remain positive on the Phase 3 data for ganetespib in 2014," notes Jefferies analyst Thomas Wei of Synta Pharmaceuticals' (SNTA +0.8%) lead drug candidate. Wei says "incremental geographic data from [a] recent analysis the GALAXY-1 trial … support the efficacy profile" of the drug. The stock is still stinging from losses incurred last month after an increase in the Hazard ratio in clinical trials made investors nervous. Nonetheless, Jefferies maintains a Buy rating and a $22 PT. Read comments

    SNTA price at time of publication: $5.04. Check SNTA price now »

3.72+0.05(+1.36%)Sep 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.